PYY peptide YY
Selected indexed studies
- Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes. (Curr Opin Endocrinol Diabetes Obes, 2021) [PMID:33395088]
- Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS). (Neuropeptides, 2020) [PMID:31727345]
- Peptide YY: A Paneth cell antimicrobial peptide that maintains Candida gut commensalism. (Science, 2023) [PMID:37535745]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Established and emerging roles peptide YY (PYY) and exploitation in obesity-diabetes. (2021) pubmed
- Possible role of peptide YY (PYY) in the pathophysiology of irritable bowel syndrome (IBS). (2020) pubmed
- Peptide YY: A Paneth cell antimicrobial peptide that maintains Candida gut commensalism. (2023) pubmed
- The origin and evolution of peptide YY (PYY) and pancreatic polypeptide (PP). (2002) pubmed
- Peptide YY and appetite control. (2004) pubmed
- Crystal structures of human neuropeptide Y (NPY) and peptide YY (PYY). (2022) pubmed
- Peptide YY: more than just an appetite regulator. (2014) pubmed
- Emerging therapeutic potential for peptide YY for obesity-diabetes. (2018) pubmed
- Peptide YY inhibits transcription and replication of hepatitis B virus by suppressing promoter/enhancer activity. (2023) pubmed
- Evolution of peptide YY analogs for the management of type 2 diabetes and obesity. (2023) pubmed